WallStreetZenWallStreetZen

NASDAQ: AFMD
Affimed Nv Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AFMD past revenue growth

How has AFMD's revenue growth performed historically?
Company
2%
Industry
69.59%
Market
14.15%
AFMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AFMD's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AFMD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AFMD earnings and revenue history

Current Revenue
$41.1M
Current Earnings
-$110.1M
Current Profit Margin
-267.6%

AFMD Return on Equity

Current Company
-62.2%
Current Industry
-18%
Current Market
30.8%
AFMD's Return on Equity (-62.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AFMD announces earnings.

AFMD Return on Assets

Current Company
-46.8%
Current Industry
0.9%
AFMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AFMD Return on Capital Employed

Current Company
-75.04%
Current Industry
14.1%
AFMD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AFMD vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AFMD$41.60M-$109.46M-$111.34M+73.42%N/A
PRTK$166.64M-$47.17M-$65.80M+67.58%N/A
CTMX$59.53M-$72.82M-$78.74M-4.30%N/A
TCRT$2.92M-$29.37M-$37.99M-9.96%N/A
CVM$0.00-$30.55M-$35.39M-100.00%N/A
View Top Biotech Stocks

Affimed Nv Earnings & Revenue FAQ

What were AFMD's earnings last quarter?

On Invalid Date, Affimed Nv (NASDAQ: AFMD) reported Q1 2023 earnings per share (EPS) of -$0.23, up 48.05% year over year. Total Affimed Nv earnings for the quarter were -$34.76 million. In the same quarter last year, Affimed Nv's earnings per share (EPS) was -$0.15.

If you're new to stock investing, here's how to buy Affimed Nv stock.

What was AFMD's earnings growth in the past year?

As of Q2 2023, Affimed Nv's earnings has grown year over year. Affimed Nv's earnings in the past year totalled -$111.34 million.

What was AFMD's revenue last quarter?

On Invalid Date, Affimed Nv (NASDAQ: AFMD) reported Q1 2023 revenue of $4.90 million up 44.28% year over year. In the same quarter last year, Affimed Nv's revenue was $8.80 million.

What was AFMD's revenue growth in the past year?

As of Q2 2023, Affimed Nv's revenue has grown 2% year over year. This is 67.6 percentage points lower than the US Biotechnology industry revenue growth rate of 69.59%. Affimed Nv's revenue in the past year totalled $41.60 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.